Skip to main content

Table 5 Evaluating performance of risk prediction modelsa

From: Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting

Parameter

Number of studies (%)

Validation

 

   Apparent

30 (77%)

   Internal

15 (38%)

Bootstrapping

2 (5%)

Jack-knifing

1 (3%)

Random split sample

10 (26%)

Cross-validation

2 (5%)

   Temporal

3 (8%)

   External

21 (54%)

Performance metricsb

 

   Discrimination

 

C-statistic

39 (100%)

D-statistic

1 (3%)

Calibrationc

10 (26%)

Hosmer-Lemeshow statistic

8 (21%)

Calibration plot

2 (5%)

   Classification

 

Reclassification (NRI)

2 (5%)

Other (for example, sensitivity, specificity)

31 (79%)

  1. aNRI,- Net Reclassification Index; bstudies can report more than one performance metric; ccalibration assessed on the basis of the development cohort in 10 studies and in the validation cohorts in 2 studies.